Get the Stockscreener App
7.49
2.47%
-0.19
After Hours:
7.49
Xeris Biopharma Holdings Inc stock is traded at $7.49, with a volume of 1.68M.
It is down -2.47% in the last 24 hours and up +2.60% over the past month.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
See More
Previous Close:
$7.68
Open:
$7.61
24h Volume:
1.68M
Relative Volume:
0.72
Market Cap:
$1.21B
Revenue:
$181.41M
Net Income/Loss:
$-59.56M
P/E Ratio:
-17.83
EPS:
-0.42
Net Cash Flow:
$-38.83M
1W Performance:
-4.59%
1M Performance:
+2.60%
6M Performance:
+63.89%
1Y Performance:
+161.89%
1-Day Range:
$7.40
$7.695
1-Week Range:
$7.40
$7.92
52-Week Range:
$2.69
$8.03
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Name
Xeris Biopharma Holdings Inc
Sector
Industry
Phone
844-445-5704
Address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Compare XERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
7.49 | 1.26B | 181.41M | -59.56M | -38.83M | -0.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Resumed | H.C. Wainwright | Buy |
| Nov-11-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-28-24 | Initiated | Oppenheimer | Outperform |
| Aug-28-23 | Initiated | Craig Hallum | Buy |
| Oct-21-22 | Initiated | Jefferies | Buy |
| Apr-28-22 | Initiated | Craig Hallum | Buy |
| Nov-17-21 | Initiated | SVB Leerink | Outperform |
| Oct-29-21 | Initiated | H.C. Wainwright | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Feb-18-20 | Initiated | Piper Sandler | Overweight |
| Jul-16-18 | Initiated | Jefferies | Buy |
| Jul-16-18 | Initiated | Leerink Partners | Outperform |
| Jul-16-18 | Initiated | RBC Capital Mkts | Outperform |
View All
Xeris Biopharma Holdings Inc Stock (XERS) Latest News
Persky, Xeris biopharma director, sells $119k in XERS stock - Investing.com
Persky, Xeris biopharma director, sells $119k in XERS stock By Investing.com - Investing.com UK
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Significant Decrease in Short Interest - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Cut to "Buy" at Wall Street Zen - MarketBeat
Parkman Healthcare Partners LLC Has $9.78 Million Stock Holdings in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Cubist Systematic Strategies LLC Takes $4.46 Million Position in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Graham Capital Management L.P. Grows Position in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
What Makes Xeris Biopharma (XERS) a Strong Momentum Stock: Buy Now? - Yahoo Finance
85,111 Shares in Xeris Biopharma Holdings, Inc. $XERS Bought by Bosun Asset Management LLC - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Hits New 52-Week HighStill a Buy? - MarketBeat
What’s the RSI of Xeris Biopharma Holdings Inc. stock2025 Macro Impact & Free Community Supported Trade Ideas - beatles.ru
Is Xeris Biopharma Holdings Inc. stock a top performer YTDBear Alert & AI Driven Price Predictions - خودرو بانک
Is Xeris Biopharma Holdings Inc. forming bullish engulfing patterns2025 Trading Recap & Verified Swing Trading Watchlist - خودرو بانک
Quarry LP Invests $388,000 in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Is Xeris Biopharma Holdings Inc. stock a good dividend stockJuly 2025 Levels & Weekly High Potential Stock Alerts - خودرو بانک
Candlestick signals on Xeris Biopharma Holdings Inc. stock todayPortfolio Growth Summary & Real-Time Sentiment Analysis - Newser
Is Xeris Biopharma Holdings Inc. stock risky to hold nowBreakout Watch & High Accuracy Buy Signal Tips - خودرو بانک
Layoff Watch: Is Xeris Biopharma Holdings Inc. a good stock for dollar cost averaging2025 Key Highlights & AI Powered Market Trend Analysis - خودرو بانک
Technical signs of recovery in Xeris Biopharma Holdings Inc.2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
Xeris In Recorlev-Fueled Growth: Why I Choose To Buy (NASDAQ:XERS) - Seeking Alpha
Is Xeris Biopharma Holdings Inc. forming a breakout patternJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - خودرو بانک
Institutional scanner results for Xeris Biopharma Holdings Inc.2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Alpine Global Management LLC Cuts Stock Holdings in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Developing predictive dashboards with Xeris Biopharma Holdings Inc. dataTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
Technical analysis overview for Xeris Biopharma Holdings Inc. stock2025 Market Outlook & Reliable Breakout Forecasts - Newser
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD By Investing.com - Investing.com Canada
Russell Investments Group Ltd. Acquires 113,713 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Using data models to predict Xeris Biopharma Holdings Inc. stock movementPortfolio Risk Summary & Safe Capital Allocation Plans - Newser
Is Xeris Biopharma Holdings Inc. stock bottoming outPortfolio Update Report & Verified Technical Trade Signals - Newser
Can a trend reversal in Xeris Biopharma Holdings Inc. lead to recoveryForecast Cut & Free Growth Oriented Trading Recommendations - Newser
Bank Watch: Can Xeris Biopharma Holdings Inc. expand its profit marginsOil Prices & High Return Trade Guides - khodrobank.com
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD - Investing.com
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue - MSN
What’s the fair value of Xeris Biopharma Holdings Inc. stockWall Street Watch & Risk Managed Investment Entry Signals - خودرو بانک
How cyclical is Xeris Biopharma Holdings Inc.’s revenue streamMarket Activity Report & Safe Entry Momentum Stock Tips - خودرو بانک
Is Xeris Biopharma Holdings Inc. stock a smart retirement pickWeekly Market Report & Low Drawdown Investment Ideas - خودرو بانک
Can Xeris Biopharma Holdings Inc. expand its profit marginsJuly 2025 Decliners & Verified Entry Point Detection - خودرو بانک
Quantbot Technologies LP Invests $297,000 in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Investor Mood: Can Xeris Biopharma Holdings Inc. expand its profit margins2025 Major Catalysts & Low Drawdown Trading Techniques - خودرو بانک
What is Xeris Biopharma Holdings Inc.’s book value per shareTrade Entry Report & Low Risk High Win Rate Stock Picks - خودرو بانک
Will Xeris Biopharma Holdings Inc. see short term momentumGap Up & Daily Growth Stock Tips - Newser
Is Xeris Biopharma Holdings Inc. showing signs of accumulationChart Signals & Real-Time Chart Pattern Alerts - Newser
Jump Financial LLC Buys 394,739 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma Holdings Inc Stock (XERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):